ACTIVE

BIOGNOST

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

3,1 M €

-14.6% YoY

Gross margin

3,9 M €

-12.3% YoY

Equity

4,9 M €

+167.6% YoY

Workforce

10,9 ETP

+4.8% YoY

What does BIOGNOST do?

BIOGNOST is a Private limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kortrijk. It employs on average 10,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0456.661.548

Incorporation

20/12/1995

Legal form

Private limited company

Registered office

Waterven(Heu) 11
8501 Kortrijk · FlandreSee on map

Contributed capital

62 500,00 €

Latest accounts

31/12/2025

Average workforce

10,9 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 71209Technical testing and analysis 71209Technical testing and analysis 74302Translation and interpretation activities

Joint committees (3)

14904
200
218

Contacts

3 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	3,9 M €	-12.3%	4,4 M €	+9.2%	4 M €	+5.2%	3,8 M €	+12.1%	3,4 M €	+29.1%	2,7 M €	+5.9%	2,5 M €	+20.4%	2,1 M €	-32.0%	3,1 M €	+28.8%	2,4 M €	+15.7%	2,1 M €	+6.1%	1,9 M €	+4.0%	1,9 M €	-1.9%	1,9 M €	-4.3%	2 M €	+2.5%	1,9 M €	-1.5%	2 M €
EBITDA	2,7 M €	-21.6%	3,4 M €	+11.6%	3,1 M €	+4.0%	3 M €	+14.0%	2,6 M €	+42.1%	1,8 M €	+5.2%	1,7 M €	+18.0%	1,5 M €	-25.5%	2 M €	+57.3%	1,3 M €	+18.3%	1,1 M €	-6.6%	1,1 M €	+9.3%	1 M €	+0.2%	1 M €	-13.9%	1,2 M €	-1.0%	1,2 M €	+0.1%	1,2 M €
Operating result	2,5 M €	-24.6%	3,3 M €	+11.2%	3 M €	+5.2%	2,8 M €	+14.8%	2,5 M €	+51.1%	1,6 M €	+6.4%	1,5 M €	+21.4%	1,3 M €	-27.9%	1,7 M €	+59.8%	1,1 M €	+15.2%	950,5 k €	-8.5%	1 M €	+16.7%	890,5 k €	+2.6%	868,2 k €	-13.2%	999,8 k €	+2.8%	972,1 k €	+1.3%	960 k €
Net result	3,1 M €	-14.6%	3,6 M €	+16.3%	3,1 M €	+3.6%	3 M €	+17.2%	2,6 M €	+47.7%	1,7 M €	+18.6%	1,5 M €	+85.7%	785,8 k €	-33.7%	1,2 M €	+59.4%	743,8 k €	+11.7%	665,7 k €	+0.6%	662,1 k €	+11.0%	596,6 k €	+0.5%	593,9 k €	-14.5%	694,8 k €	+6.0%	655,7 k €	+6.9%	613,4 k €
Balance sheet
Equity	4,9 M €	+168%	1,8 M €	+20.2%	1,5 M €	+24.8%	1,2 M €	+67.9%	730,5 k €	+175%	265,2 k €	-83.6%	1,6 M €	+61.8%	998,1 k €	-25.4%	1,3 M €	+34.0%	998,6 k €	-39.7%	1,7 M €	+1.0%	1,6 M €	+3.9%	1,6 M €	+0.4%	1,6 M €	-36.6%	2,5 M €	+39.0%	1,8 M €	+34.4%	1,3 M €
Total assets	7,3 M €	+3.7%	7 M €	+15.4%	6,1 M €	+10.4%	5,5 M €	+11.2%	4,9 M €	+9.3%	4,5 M €	+12.9%	4 M €	+38.5%	2,9 M €	-3.1%	3 M €	+1.5%	2,9 M €	+10.2%	2,7 M €	+7.0%	2,5 M €	+10.5%	2,3 M €	-9.8%	2,5 M €	-28.9%	3,5 M €	+13.4%	3,1 M €	+6.8%	2,9 M €
Cash	2,5 M €	-28.1%	3,5 M €	+33.5%	2,6 M €	+41.0%	1,9 M €	-28.8%	2,6 M €	+82.2%	1,4 M €	-25.7%	1,9 M €	+209%	624,9 k €	+13.8%	548,9 k €	-43.7%	975 k €	-10.9%	1,1 M €	+47.1%	744,2 k €	+81.7%	409,5 k €	-35.0%	630,5 k €	+464%	111,8 k €	-92.3%	1,4 M €	+41.7%	1 M €
Debts	2,3 M €	-54.8%	5,2 M €	+14.2%	4,5 M €	+6.2%	4,3 M €	+1.3%	4,2 M €	+0.1%	4,2 M €	+79.2%	2,3 M €	+23.9%	1,9 M €	+15.6%	1,6 M €	-15.8%	1,9 M €	+91.9%	1 M €	+19.4%	847,6 k €	+25.7%	674,2 k €	-27.0%	924 k €	-11.1%	1 M €	-21.2%	1,3 M €	-16.3%	1,6 M €
Other
Workforce	10,9 ETP	+4.8%	10,4 ETP	+3.0%	10,1 ETP	-1.0%	10,2 ETP	-6.4%	10,9 ETP	-4.4%	11,4 ETP	+3.6%	11,0 ETP	+22.2%	9,0 ETP	-4.3%	9,4 ETP	-1.1%	9,5 ETP	-1.0%	9,6 ETP	+11.6%	8,6 ETP	-22.5%	11,1 ETP	-5.9%	11,8 ETP	+6.3%	11,1 ETP	+3.7%	10,7 ETP	-15.7%	12,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

BIOGNOST FILIA

Director · since 29 août 2022 · 0788.534.972

Represented by Janne Masschelein

Active

Ended mandates

Janne Masschelein

Director · since 10 janvier 2022 · until 30 septembre 2022

Ended

Geert Masschelein

Director · since 20 décembre 1995 · until 31 mars 2022

Ended

Geert Masschelein

Director · since 20 décembre 1995

Ended

Geert Masschelein

Manager · since 20 décembre 1995

Ended

At this address

Other companies at this address

Company	CBE no.
BIOGNOST FILIA● Active	0788.534.972
BIOGNOST IMMO● Active	0597.831.091

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/06/2026	23/06/2025	21/06/2024	05/06/2023	06/09/2022	23/06/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	26/05/2023	16/08/2022	21/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	24/06/2026	Dutch	PDF
Abridged model	31/12/2024	20/06/2025	23/06/2025	Dutch	PDF
Abridged model	31/12/2023	21/06/2024	21/06/2024	Dutch	PDF
Abridged model	31/12/2022	26/05/2023	05/06/2023	Dutch	PDF
Abridged model	31/12/2021	16/08/2022	06/09/2022	Dutch	PDF
Abridged model	31/12/2020	21/05/2021	23/06/2021	Dutch	PDF
Abridged model	31/12/2019	15/05/2020	13/07/2020	Dutch	PDF
Abridged model	31/12/2018	26/06/2019	10/07/2019	Dutch	PDF
Abridged model	31/12/2017	18/05/2018	11/07/2018	Dutch	PDF
Abridged model	31/12/2016	19/05/2017	10/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/05/2016	20/07/2016	Dutch	PDF
Abridged model	31/12/2014	31/03/2015	27/04/2015	Dutch	PDF
Abridged model	31/12/2013	16/05/2014	16/09/2014	Dutch	PDF
Abridged model	31/12/2012	17/05/2013	23/08/2013	Dutch	PDF
Abridged model	31/12/2011	18/05/2012	12/07/2012	Dutch	PDF
Abridged model	31/12/2010	20/05/2011	31/08/2011	Dutch	PDF
Abridged model	31/12/2009	21/05/2010	31/08/2010	Dutch	PDF
Abridged model	31/12/2008	15/05/2009	14/07/2009	Dutch	PDF
Abridged model	31/12/2007	16/05/2008	25/06/2008	Dutch	PDF
Abridged model	31/12/2006	18/05/2007	03/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

BIOGNOST FILIA

Director · since 29 août 2022 · 0788.534.972

Represented by Janne Masschelein

Active

Ended mandates

Janne Masschelein

Director · since 10 janvier 2022 · until 30 septembre 2022

Ended

Geert Masschelein

Director · since 20 décembre 1995 · until 31 mars 2022

Ended

Geert Masschelein

Director · since 20 décembre 1995

Ended

Geert Masschelein

Manager · since 20 décembre 1995

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates26/09/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/05/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/01/2022
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/08/2015
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Restructuring19/02/2015
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring21/01/2015
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Capital / shares28/10/2008
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20253,1 M €↓
2024
Annual accounts 20243,6 M €↑
2023
Annual accounts 20233,1 M €↑
2022
Annual accounts 20223 M €↑
2021
Annual accounts 20212,6 M €↑
2018
Annual accounts 20181,7 M €↑
2017
Annual accounts 20171,5 M €↑
2016
Annual accounts 2016785,8 k €↓
2015
Annual accounts 20151,2 M €↑
2013
Annual accounts 2013743,8 k €↑
2012
Annual accounts 2012665,7 k €↑
2011
Annual accounts 2011662,1 k €↑
2010
Annual accounts 2010596,6 k €↑
2009
Annual accounts 2009593,9 k €↓
2008
Annual accounts 2008694,8 k €↑
2007
Annual accounts 2007655,7 k €↑
2006
Annual accounts 2006613,4 k €
20/12/1995
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

BIOGNOST

Overview

What does BIOGNOST do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline